Corrigendum to: Mechanistic target of rapamycin (mTOR) protein expression in the tumor and its microenvironment correlates with more aggressive pathology at cystectomy

Affiliations

• ¹ Department of Urology, University of Washington School of Medicine, Seattle, WA.
• ² Department of Pathology, University of Washington School of Medicine, Seattle, WA.
• ³ Department of Medicine, University of Washington School of Medicine, Seattle, WA.
• ⁴ Department of Urology, University of Bern, Bern, Switzerland.
• ⁵ Department of Urologic Sciences, University of British Columbia, Canada.
• ⁶ Department of Urology, University Medical Center Rotterdam, Rotterdam, The Netherlands.
• ⁷ UC Davis Comprehensive Cancer Center, Sacramento, CA.
• ⁸ GenomeDx Biosciences, Inc., Vancouver, British Columbia, Canada.
• ⁹ Department of Urology, University Hospital of Southampton, Hampshire, UK.
• ¹⁰ Department of Surgical Oncology, Division of Urology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
• ¹¹ Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA.
• ¹² Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA.
• ¹³ Department of Urology, University of Washington School of Medicine, Seattle, WA. Electronic address: minglam@uw.edu.